-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RgY1hxEhHHgy+TpOzQ2JI92ZSXRkFo3tSbjRfjPlloD8EG6zRFe4GJHz+lR1k+81 TnRo/oOqYB6veBzxmCDkfw== 0000889812-98-002523.txt : 19981028 0000889812-98-002523.hdr.sgml : 19981028 ACCESSION NUMBER: 0000889812-98-002523 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981027 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ANGEION CORP/MN CENTRAL INDEX KEY: 0000815093 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411579150 STATE OF INCORPORATION: MN FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-40187 FILM NUMBER: 98731343 BUSINESS ADDRESS: STREET 1: 7601 NORTHLAND DRIVE STREET 2: STE 170 CITY: BROOKLYN PARK STATE: MN ZIP: 55428 BUSINESS PHONE: 6123152000 MAIL ADDRESS: STREET 1: 7601 NORTHLAND DRIVE STREET 2: SUITE 170 CITY: BROOKLYN PARK STATE: MN ZIP: 55428 FORMER COMPANY: FORMER CONFORMED NAME: VERDE VENTURES INC DATE OF NAME CHANGE: 19880714 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SYNTHELABO CENTRAL INDEX KEY: 0001051557 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 22 AVENUE GALILEE STREET 2: 92350 LE PLESSIS ROBINSON CITY: FRANCE STATE: I0 ZIP: 00000 SC 13D/A 1 AMENDMENT NO. 2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a) Amendment No. 2* Angeion Corporation -------------------------------------------- (Name of Company) Common Stock, par value $.01 per share -------------------------------------------- (Title of Class of Securities) 03462H 10 7 -------------------------------------------- (CUSIP Number) James C. Colihan, Esq. Coudert Brothers 1114 Avenue of the Americas New York, NY 10036 (212) 626-4400 -------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 15, 1998 -------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 2 of 11 Pages CUSIP No. 03462H 10 7 13D - -------------------------------------------------------------------------------- 1 Name of Reporting Person Synthelabo S.S. or I.R.S. Identification No. of Above Person 000-00-0000 - -------------------------------------------------------------------------------- 2 Check the Appropriate Box If a Member of a Group* a. /__/ b. /__/ - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Source of Funds* 00(1) - -------------------------------------------------------------------------------- 5 Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) /__/ - -------------------------------------------------------------------------------- 6 Citizenship or Place of Organization France - -------------------------------------------------------------------------------- 7 Sole Voting Power Number of 11,935,935 Shares Beneficially 8 Shared Voting Power Owned By 0 Each Reporting 9 Sole Dispositive Power Person 11,935,935 With 10 Shared Dispositive Power 0 - -------------------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 11,935,935 - -------------------------------------------------------------------------------- 12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* /__/ - -------------------------------------------------------------------------------- 13 Percent of Class Represented By Amount in Row (11) 21.8% - -------------------------------------------------------------------------------- - -------- (1) The Supplemental Shares and Supplemental Warrants have been issued in this transaction without consideration in accordance with the Investment Agreement, as described in Item 4. Page 3 of 11 Pages 14 Type of Reporting Person CO - -------------------------------------------------------------------------------- * SEE INSTRUCTIONS BEFORE FILLING OUT! Page 4 of 11 Pages This Amendment No. 2 (this "Amendment") to the Schedule 13D filed on December 19, 1997 (the "Schedule 13D") on behalf of Synthelabo, a societe anonyme organized under the laws of France ("Synthelabo"), relates to the Common Stock, par value $.01 per share ("Common Stock"), of Angeion Corporation, a Minnesota corporation (the "Issuer"), and is being filed pursuant to Rule 13d-2 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13D. Item 1. Security and Company. This Amendment relates to the Common Stock of the Issuer. The address of the principal executive offices of the Issuer is 7601 Northland Drive, Brooklyn Park, MN 55428. Item 2. Identity and Background. Schedule A to the Schedule 13D, attached hereto, has been modified to reflect current information. Item 3. Source and Amount of Funds or Other Consideration. This Amendment relates to the acquisition (the "Acquisition") as of October 15, 1998 by Synthelabo of (i) 3,846,153 additional shares of Common Stock of the Issuer (the "Supplemental Shares"), and (ii) a Common Stock Purchase Warrant (the "Supplemental Warrant") entitling Synthelabo to acquire an additional 2,307,692 shares of Common Stock of the Issuer pursuant to the Amended and Restated Investment and Master Strategic Relationship Agreement, dated as of October 9, 1997, between the Issuer and Synthelabo (the "Investment Agreement"). The Supplemental Shares and Supplemental Warrants were issued without consideration as an adjustment to Synthelabo's initial investment pursuant to the Investment Agreement. Item 4. Purpose of Transaction. Pursuant to the Investment Agreement, Synthelabo acquired the Supplemental Shares and the Supplemental Warrant as an adjustment to the 2,251,408 shares of the Issuer's Common Stock (the "Initial Shares") and Common Stock Purchase Warrant (the "Warrant") initially acquired by Synthelabo on December 9, 1997. The Warrant entitled Synthelabo to purchase an additional 1,350,845 shares of the Issuer's Common Stock pursuant to the Investment Agreement. The Supplemental Shares were calculated in accordance with the Investment Agreement by dividing $15,000,000 by $2.46, representing a 30% premium over the average quoted price of the Common Stock for all trading days within the fifteen (15) trading days immediately prior to and including October 9, 1998, and subtracting therefrom the number of Initial Shares. The Supplemental Warrant is immediately exerciseable at an exercise price of $2.46 per share and has an expiration date of December 9, 2001. Synthelabo may sell all or a portion of its shares of Issuer Common Stock in open-market or private transactions, depending upon prevailing market conditions or other factors, each in accordance with and subject to the terms of the Investment Agreement and applicable securities laws. Pursuant to the Investment Agreement, Synthelabo has the right to designate one nominee to serve upon appointment or election to the Board of Directors. Page 5 of 11 Pages The Reporting Person continues to have no plans or proposals which relate to or would result in any of the events, actions or conditions specified in paragraphs (a) through (j) of the instructions to Item 4 or any similar action or effect. Nothing in this statement on Schedule 13D shall be deemed to preclude the Reporting Person from developing or implementing any such plan or proposal. Item 5. Interest in Securities of the Company. (a) Following the Acquisition, Synthelabo will be the direct owner of 7,459,959 shares of the Issuer's Common Stock, together with warrants to purchase a further 4,475,976 shares of the Issuer's Common Stock. Accordingly, based upon information contained in the Issuer's quarterly report on Form 10-Q for the period ended September 30, 1998 and filed on October 15, 1998, as well as information obtained from the Issuer. Synthelabo will be the direct owner of 19.4% of the issued and outstanding shares of the Issuer's Common Stock as a result of the 7,459,959 shares owned by Synthelabo (21.8% of such issued and outstanding shares of the Issuer's Common Stock as a result of such shares and the 4,475,976 shares underlying the warrants). (b) Synthelabo has sole power to vote and dispose of all of the shares beneficially owned by it as reported above. (c) Synthelabo acquired the Supplemental Shares and the Supplemental Warrants as of October 15, 1998 in a privately negotiated transaction. (d) Not applicable. (e) Not applicable. Page 6 of 11 Pages SIGNATURE After reasonable inquiry and to the best of their respective knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: October 27, 1998 SYNTHELABO By: /s/ Herve Guerin Name: Herve Guerin Title: President du Conseil d'Administration Page 7 of 11 Pages SCHEDULE A 1. DIRECTORS AND EXECUTIVE OFFICERS OF SYNTHELABO
Name and Principal Present Principal Business Address; Position with Employment if not Citizenship Synthelabo Stated at Left Herve Guerin President 17 avenue de Madrid du Conseil 92200 Neuilly sur Seine, de l'Administration France Citizenship: French Pierre Castres Saint-Martin Administrateur et Directeur General 11 rue Porto Riche Vice-President Adjoint de L'Oreal; 92190 Meudon, France Vice-President de L'Oreal Citizenship: French Jacques Baetz Administrateur 57 rue de Plaisance 92250 La Garenne-Colombes, France Citizenship: French Regis Dufour Administrateur 32 chemin de la Foret 78860 Saint Nom la Breteche, France Citizenship: French Pierre Meneau Administrateur Gerant de G.D.I.E. 1 Allee des Sequoias Corene Montfleury 18700 La Tronche, France Citizenship: French Yves Faivre Administrateur 88 rue la Fontaine 75016 Paris, France Citizenship: French
Page 8 of 11 Pages Pierre Lepienne Administrateur Le Moulin du Patis Vice-President Executif 02570 Chezy sur Marne, France Citizenship: Carlos Pomaret Administrateur Administrateur de l'Action Le Petit Heurteloup Sociale Pharmaceutique Longnes 78980 Breval, France Citizenship: French Gerard Chouraqui Administrateur 58 boulevard du General Leclerc 92200 Neuilly sur Seine, France Citizenship: French Salomon Zender Langer Administrateur 92 rue Jouffroy d'Abbans 75017 Paris, France Citizenship: French
2. DIRECTORS AND EXECUTIVE OFFICERS OF L'OREAL
Name and Principal Present Principal Business Address; Position with Employment if not Citizenship L'Oreal Stated at Left Lindsay Owen-Jones President du Conseil 16 rue Royale d'Administration 75008 Paris, France Citizenship: UK Pierre Castres Saint Martin Administrateur et 14 rue Royale Directeur General 75008 Paris, France Adjoint; Citizenship: French Vice-President
Page 9 of 11 Pages Francois Dalle Administrateur President de l'Institut Villa Clairefontaine International de l'Entreprise; 14 chemin du Nant d'Argent President de l'Association CH-1223 Cologny, Switzerland Entreprise et Progres Citizenship: French Guy Landon Administrateur President de Artcurial SA 14 rue Royale 75008 Paris, France Citizenship: French Marc Ladreit de Lacharriere Administrateur President de Fimalac SA 7 rue Boissonnade 75004 Paris, France Citizenship: French Olivier Lecerf Administrateur Administrateur et President 8 rue Guy de Maupassant d'Honneur de Lafarge SA 75116 Paris, France Citizenship: French Oswald Helmut Maucher Administrateur et President de Nestle SA Suisse 9 chemin de la Fin Vice-President 1802 Corseaux Canton de Vaud, Switzerland Citizenship: German Jean-Pierre Mayers Administrateur Administrateur de Gesparal 3 Rond Point Saint James et Vice-President et de Nestle SA Suisse 92200 Neuilly sur Seine, France Citizenship: French Jacques P. Visiox Administrateur 8 avenue Leon Heuzey 75016 Paris, France Citizenship: French Liliane Bettencourt Administrateur Business Woman 18 rue de Labordere Vice-President de Gesparal 9220 Neuilly sur Seine, France Citizenship: French
Page 10 of 11 Pages Edouard de Royere Administrateur Administrateur de Air Liquide 4 rue de Chanaleilles SA 75007 Paris, France Citizenship: French Francoise Bettencourt-Mayers Administrateur Administrateur de Gesparal SA 5 rue du 8 mai 1945 92110 Clichy, France Citizenship: French Peter Brabeck-Letmathe Administrateur Administrateur Delegue de 55 avenue Nestle Nestle SA Suisse; CH-1800 Vevey, Switzerland Administrateur de Gesparal Citizenship: Austrian Francisco Castander Blasco Administrateur 55 avenue Nestle CH-1800 Vevey, Switzerland Citizenship: Spanish
3. DIRECTORS AND EXECUTIVE OFFICERS OF GESPARAL
Name and Principal Present Principal Business Address; Position with Employment if not Citizenship Gesparal Stated at Left Andre Bettencourt President du Conseil 18 rue de Labordere d'Administration 92200 Neuilly sur Seine, France Citizenship: French Francois Dalle Administrateur President de l'Institut Villa Clairefontaine et Vice-President International de l'Entreprise; 14 chemin du Nant d'Argent President de l'Association CH-1223 Cologny, Switzerland Entreprise et Progres Citizenship: French Oswald Helmut Maucher Administrateur President de Nestle SA 9 chemin de la Fin et Vice-President Suisse 1802 Canton de Vaud, Switzerland Citizenship: German
Page 11 of 11 Pages Jose Daniel Gubert Administrateur Chemin de Plantaz, 65 CH-1095 Lutry Switzerland Citizenship: Spanish Liliane Bettencourt Vice-President et Business Woman 18 rue de Labordere Administrateur 92200 Neuilly sur Seine, France Citizenship: French Francoise Bettencourt-Mayers Administrateur Administrateur de Gesparal SA 5 rue du 8 mai 1945 92110 Clichy, France Citizenship: French Jean-Pierre Mayers Administrateur Administrateur de Gesparal 3 Rond Point Saint James et Vice-President et Nestle SA Suisse 92200 Neuilly sur Seine, France Citizenship: French Lindsay Owen-Jones President du Conseil 16 rue Royale d'Administration 75008 Paris, France Citizenship: UK Peter Brabeck-Letmathe Administrateur Administrateur Delegue de 55 avenue Nestle Nestle SA Suisse CH-1800 Vevey, Switzerland Citizenship: Austrian Francisco Castaner Blasco Administrateur 55 avenue Nestle CH-1800 Vevey, Switzerland Citizenship: Spanish
-----END PRIVACY-ENHANCED MESSAGE-----